Search Results - "MART'YANOV, V. A"

Preclinical Pharmacokinetic and Pharmacodynamic Studies of Pharmaceutical Compositions of the Dipeptide Anxiolytic GB-115 by Zherdev, V. P., Boiko, S. S., Konstantinopol’skii, M. A., Raskin, S. Yu, Alekseev, K. V., Gudasheva, T. A., Mart’yanov, V. A., Kolik, L. G.

“…Four pharmaceutical compositions for oral use that contained the dipeptide anxiolytic GB-115 as the active ingredient underwent preclinical trials in male…”
Get full text

Recombinant granulocyte colony stimulating factor (filgrastim) of prolonged action: Optimization of conditions for extraction and purification from inclusion bodies by Kononova, N. V., Yakovlev, A. V., Zhuravko, A. M., Pankeev, N. N., Minaev, S. V., Bobruskin, A. I., Mart’yanov, V. A.

“…A unified technology platform for the production of two medical products with nonprolonged and prolonged action on the basis of the recombinant human…”
Get full text

Recombinant granulocyte colony-stimulating factor (filgrastim): Optimization of conjugation conditions with polyethylene glycol by Puchkov, I. A., Kononova, N. V., Bobruskin, A. I., Bairamashvili, D. I., Mart’yanov, V. A., Shuster, A. M.

“…With the purpose of creating an active prolonged-release pharmaceutical substance, modification of the recombinant human granulocyte colony-stimulating factor…”
Get full text

90-MW single-shaft power generating steam-gas unit based on the GTÉ-65 gas turbine and K-30-60 steam turbine by Lebedev, A. S., Antonyuk, O. V., Mart’yanov, V. A., Gordeev, N. N., Sergeev, A. G., Konashkov, V. A.

“…This is an examination of a variant of the monoblock PGU-90 steam-gas unit developed at the “Leningradskii Metallicheskii Zavod” (LMZ) branch of “Silovye…”
Get full text

Development and optimization of several stages of the technological process of filgrastim substance production by Kononova, N. V, Bobruskin, A. I, Kostromina, T. I, Melikhova, T. D, Vainson, A. A, Sveshnikova, E. V, Zinchenko, A. A, Demin, A. V, Martyanov, V. A, Shuster, A. M, Bairamashvili, D. I

“…Technology of industrial production of an active pharmaceutical substance (APS) of the recombinant human granulocyte colony-stimulating factor (rhG-CSF)…”
Get full text

Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors by Neznamov, G G, Dorofeeva, O A, Metlina, M V, Syunyakov, T S, Minaev, S V, Ivashkina, N Yu, Martyanov, V A, Seredenin, S B

“…To evaluate anxiolytic action of GB-115, a low-affinity blocker of central cholecystokinin receptors, used in tablets in a dose of 1 mg for the treatment of…”
Get more information

Pharmacological Correction of Alcohol Motivation Depends on the Phenotype of the Response to Emotional Stress by Kolik, L. G., Gudasheva, T. A., Martyanov, V. A., Seredenin, S. B.

“…The specific features of alcohol behavior were studied in MR and MNRA rats that exhibit an opposite reaction to emotional stress. We evaluated the effect of a…”
Get full text

Resistance of titanium nickelide TN-1K to deformation at rates of 10-3-103 per second by POPOV, N. N, MART'YANOV, V. A

Get full text

EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES by Kolik, L G, Zherdev, V P, Boiko, S S, Konstantinopol'skii, M A, Raskin, S Yu, Gudasheva, T A, Mart'yanov, V A, Seredenin, S B

“…Pharmacokinetics and pharmacological activity of GB-115 dipeptide anxiolytic after oral administration in the form of crystalline and micronized substances was…”
Get more information

Resistance of Titanium Nickelide TN-1K to Deformation at Rates of 10 exp -3 -10 exp 3 /s [[Previously Titled: Resistance to Deformation of Titanium Nickelide TN-1K at 10 exp -3 -10 exp 3 s exp -1 Deformation Rate.]] by Popov, N N, Mart'yanov, V A

“…Previously abstracted from original as item 9403-31-1513. Resistance to deformation of titanium nickelide at different deformation rate has been investigated…”
Get full text

AMts alloy cracking resistance, strength, strain and energy characteristics at strain rates of 10 exp -3 -10 exp 3 s exp -1 [[Previously Titled: Cracking resistance, strength, deformation and power characteristics of alloy type AMts at strain rates of 10 exp -3 -10 exp 3 C exp -1 .]] by Popov, N N, Mart'yanov, V A, Ponomarev, V A

“…Previously abstracted from original as items Metals Abstracts 199505-31-1401, Aluminium Industry Abstracts 199505-R.5-0428. Low-scale specimens of low strength…”
Get full text

AMts alloy cracking resistance, strength, strain, and energy characteristics at strain rates of 10?3?103 sec?1 by Popov, N. N., Mart'yanov, V. A., Ponomarev, V. A.

Get full text

Strength and cracking resistance of AMts aluminum alloy at strain rates of 10−3,103 sec−1 by Popov, N. N., Mart'yanov, V. A., Ponomarev, V. A.

Get full text

Strength and cracking resistance of AMts aluminium alloy under deformation rates 10 exp )3 )10 exp 3 s exp )1 [[Previously Titled: Strength and crack-resistance of aluminium alloy AM under deformation rates 10 exp )3 )10 exp 3 s exp )1 .]] by Popov, N N, Mart'yanov, V A, Ponomarev, V A

“…See Met. A. 199405-31-2067. The values of crack resistant parameter K sub lambda , as well as a number of standard and nonstandard deformation and energy…”
Get full text

Plastic deformation resistance of an indium-lead alloy with strain rates of 10?3?103 sec?1 by Popov, N. N., Mart'yanov, V. A., Bezrukov, S. G.

Get full text

Dipeptide cholecystokinin-4 analog attenuates anxiety in "high-emotional" mice BALB/c and in ethanol-withdrawn rats: comparison with phenazepam by L. G. Kolik, A. V. Nadorova, T. A. Gudasheva, V. A. Martyanov, S. B. Seredenin

“…Anxiolytic effects of dipeptide endogenous cholecystokinin tetrapeptide analogue GB-115 at the dose range 0,25-2,0 mg/ kg after oral administration were…”
Get full text

Strength and cracking resistance of AMts aluminium alloy at strain rates of 10-3-103 sec-1 by POPOV, N. N, MART'YANOV, V. A, PONOMAREV, V. A

Get full text